New Delhi, May 5 -- AstraZeneca, in partnership with health-tech company Qure.ai, recently announced the successful completion of 5 million artificial intelligence (AI)-enabled chest X-rays (CXRs) across more than 20 countries in Asia, the Middle East, Africa, and Latin America. This milestone-part of AstraZeneca's commitment to the World Economic Forum's EDISON Alliance 1 Billion Lives Challenge-demonstrates the potential of AI in improving lung cancer detection, particularly in resource-limited healthcare settings.

The AI-enabled CXRs identified high-risk lung nodules in nearly 50,000 individuals, prompting referrals for further testing and potential diagnoses.

The EDISON Alliance's 1 Billion Lives Challenge, launched in 2022, aims to...